Tafenoquine combinations show promising parasite clearance in immunocompromised patients with babesiosis
60 Degrees Pharmaceuticals reports negative Babesia PCR tests in five patients receiving tafenoquine combinations, with FDA discussions planned.
Pharma & Biotech